Published in Mental Health Business Week, May 7th, 2005
Jochelson is responsible for leading all phases of the clinical development of Somaxon's portfolio of compounds through NDA submission and approval. He also will be responsible for medical affairs and medical marketing support for commercialized products and will also lead the medical and clinical assessment of future in-licensing opportunities.
Jochelson previously was vice president, clinical development, Neurocrine Biosciences,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.